Seroatlas · Human Serome Atlas

FAR2

Fatty acyl-CoA reductase 2

Also known as: FACR2_HUMAN, FLJ10462, MLSTD1, SDR10E2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q96K12
Gene
FAR2
Ensembl
ENSG00000064763
Chromosome
12
Canonical length
515 aa
Protein class
Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Nucleoli,Golgi apparatus

OverviewNCBI Gene

This gene belongs to the short chain dehydrogenase/reductase superfamily. It encodes a reductase enzyme involved in the first step of wax biosynthesis wherein fatty acids are converted to fatty alcohols. The encoded peroxisomal protein utilizes saturated fatty acids of 16 or 18 carbons as preferred substrates. Alternatively spliced transcript variants have been observed for this gene. Related pseudogenes have been identified on chromosomes 2, 14 and 22. [provided by RefSeq, Nov 2012]

Canonical amino-acid sequenceUniProt

515 residues, UniProt reviewed canonical sequence.

>Q96K12|FAR2
     1  MSTIAAFYGG KSILITGATG FLGKVLMEKL FRTSPDLKVI YILVRPKAGQ TLQQRVFQIL
    61  DSKLFEKVKE VCPNVHEKIR AIYADLNQND FAISKEDMQE LLSCTNIIFH CAATVRFDDT
   121  LRHAVQLNVT ATRQLLLMAS QMPKLEAFIH ISTAYSNCNL KHIDEVIYPC PVEPKKIIDS
   181  LEWLDDAIID EITPKLIRDW PNIYTYTKAL GEMVVQQESR NLNIAIIRPS IVGATWQEPF
   241  PGWVDNINGP NGIIIATGKG FLRAIKATPM AVADVIPVDT VVNLMLAVGW YTAVHRPKST
   301  LVYHITSGNM NPCNWHKMGV QVLATFEKIP FERPFRRPNA NFTSNSFTSQ YWNAVSHRAP
   361  AIIYDCYLRL TGRKPRMTKL MNRLLRTVSM LEYFINRSWE WSTYNTEMLM SELSPEDQRV
   421  FNFDVRQLNW LEYIENYVLG VKKYLLKEDM AGIPKAKQRL KRLRNIHYLF NTALFLIAWR
   481  LLIARSQMAR NVWFFIVSFC YKFLSYFRAS STLKV

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against FAR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.25
Highest tissue expression
21 nTPM

Expression across tissuesHPA

Tissue

  • colon: 21 nTPM
  • rectum: 21 nTPM
  • epididymis: 18 nTPM
  • placenta: 12 nTPM
  • small intestine: 12 nTPM
  • bone marrow: 10 nTPM

Single-cell type

  • neutrophil progenitors: 904 nCPM
  • cardiomyocytes: 714 nCPM
  • syncytiotrophoblasts: 641 nCPM
  • neutrophils: 524 nCPM
  • microglia: 267 nCPM
  • megakaryocyte progenitors: 195 nCPM

Immune cell

  • eosinophil: 39 nTPM
  • neutrophil: 23 nTPM
  • classical monocyte: 16 nTPM
  • intermediate monocyte: 9.4 nTPM
  • T-reg: 9.2 nTPM
  • total PBMC: 5.6 nTPM

Brain region

  • hypothalamus: 10 nTPM
  • basal ganglia: 8.4 nTPM
  • cerebral cortex: 7.3 nTPM
  • hippocampal formation: 6.2 nTPM
  • thalamus: 5.6 nTPM
  • white matter: 5.2 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about FAR2.

Disease | ImmuneIEDB

Conditions an epitope on FAR2 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.43
gnomAD pLI
0.56
gnomAD missense Z
1.7
DepMap mean gene effect
-0.26
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads FAR2 as an antibody target. Whether an autoantibody or antibody against FAR2 could matter depends on whether native FAR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

FAR2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label FAR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/FAR2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...